Back to Search Start Over

Recombinant α2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.

Authors :
Lai, C-L
Wu, P-C
Lok, AS-F
Lin, H-J
Ngan, H
Lau, JY-N
Chung, H-T
Ng, MM-T
Yeoh, E-K
Arnold, M
Source :
British Journal of Cancer; Dec1989, Vol. 60 Issue 6, p928-933, 6p
Publication Year :
1989

Details

Language :
English
ISSN :
00070920
Volume :
60
Issue :
6
Database :
Complementary Index
Journal :
British Journal of Cancer
Publication Type :
Academic Journal
Accession number :
61383938
Full Text :
https://doi.org/10.1038/bjc.1989.392